Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Pennsylvania Gov. Josh Shapiro accused Kamala Harris of lying about him in her new memoir, causing tensions among Democrats. Shapiro also criticized Harris for losing ground in blue-collar regions and for her handling of the vetting process. Other Democrats have also spoken out against Harris's book, including Gavin Newsom and Pete Buttigieg.
Leading cryptocurrencies lifted alongside stocks on Wednesday, as soft private jobs data strengthened investor hopes that the Federal Reserve would slash interest rates next week.
Nvidia CEO Jensen Huang's journey from mistakenly being sent to a Kentucky reform school as a child to building a trillion-dollar tech empire highlights how early hardship shaped one of the most influential leaders in the global AI industry.
The selection of Bad Bunny to perform at halftime at Super Bowl LX has divided fans. A look at Spotify's 2025 list of top artists, albums and songs could show why he may have been chosen.
Congresswoman Marjorie Taylor Greene (R-Ga.) has been actively buying up shares of a Bitcoin ETF in 2025. A new disclosure shows another purchase, which came during a dip in the price of the leading cryptocurrency.
Transportation stocks are rallying on expectations of economic growth. Factors include rising rate-cut expectations, falling yields, and easing fuel prices.
Carvana shares are trading higher Wednesday as investors piled into small caps on growing conviction that the Federal Reserve will cut interest rates at next week's policy meeting.
Trump's call with Brazil President Lula boosts hopes of a trade thaw, putting EWZ ETF back in focus amid potential tariff relief and optimism for Brazilian equities.
William Blair starts coverage of Viridian, citing veligrotug's advantages over Tepezza and key 2026 catalysts, including FDA review and VRDN-003 Phase 3 data.
Zynlonta and glofitamab show high response and durable remission rates in early r/r DLBCL trial data from ADC Therapeutics, with enrollment ongoing into 2026.
Marvell Technology (NASDAQ: MRVL) stock rose after beating Q3 earnings estimates. Analysts raised price forecasts due to strong data center outlook and Celestial AI acquisition.
